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The additivity of substrate fragments in enzyme–ligand binding
Thomas J Stout†, Carleton R Sage† and Robert M Stroud*
Background: Enzymes have evolved to recognise their target substrates with
exquisite selectivity and specificity. Whether fragments of the substrate —
perhaps never available to the evolving enzyme — are bound in the same manner
as the parent substrate addresses the fundamental basis of specificity. An
understanding of the relative contributions of individual portions of ligand
molecules to the enzyme-binding interaction may offer considerable insight into
the principles of substrate recognition.
Results: We report 12 crystal structures of Escherichia coli thymidylate
synthase in complexes with available fragments of the substrate (dUMP), both
with and without the presence of a cofactor analogue. The structures display
considerable fidelity of binding mode and interactions. These complexes
reveal several interesting features: the cofactor analogue enhances the
localisation of substrate and substrate fragments near the reactive thiol; the
ribose moiety reduces local disorder through additional specific
enzyme–ligand interactions; the pyrimidine has multiple roles, ranging from
stereospecificity to mechanistic competence; and the glycosidic linkage has
an important role in the formation of a covalent attachment between substrate
and enzyme.
Conclusions: The requirements of ligand–protein binding can be understood
in terms of the binding of separate fragments of the ligand. Fragments which
are subsystems of the natural substrate for the enzyme confer specific
contributions to the binding affinity, orientation or electrostatics of the enzymatic
mechanism. This ligand-binding analysis provides a complementary method to
the more prevalent approaches utilising site-directed mutagenesis. In addition,
these observations suggest a modular approach for rational drug design
utilising chemical fragments.
Introduction
One of the fundamentals of life at the molecular level is
that enzymes are required to act upon their substrates
with speed, precision and fidelity. As a result, evolution-
ary pressures have caused these proteins to develop
recognition systems for their target substrates which
function with exquisite selectivity and specificity. Studies
of the interactions between enzymes and their substrates
have generally found that multiple interactions are typi-
cally generated within the enzyme around the available
‘hooks’ presented by the substrate. This multidentate
approach to ligand binding provides the enzymatic
system with both selectivity (improving the odds that the
binding of similar but slightly different ligands will be
disfavoured), and precision (lining up the substrate in a
mechanistically competent orientation). The question of
whether fragments of the substrate — individually perhaps
never available to the evolving enzyme and thus not a
component of the selective pressures of evolution —
are bound in the same manner as the parent substrate
addresses the fundamental basis of enzyme specificity.
If additivity of components, in both energetic and
structural terms, is realised, considerable insight may be
gained into the principles of substrate recognition as well
as providing a contribution to combinatorial approaches
to drug design.
Because production of dTMP is a requirement for DNA
synthesis and therefore cell division, thymidylate syn-
thase (TS), the only biosynthetic source of cellular dTMP,
has been extensively studied both as a drug target and as
a model enzymatic system. Early studies of the catalytic
mechanism of TS using organic chemical analogues pro-
posed that the key step of the TS reaction involved the
formation of a covalent bond between the substrate and a
critical cysteine residue [1]. Investigations using molecu-
lar biology to alter TS residue by residue allowed an
analysis of which amino acid residues were important in
the TS reaction [1]. The determination of various TS
crystal structures alone and in complexes with substrates
and substrate analogues [2–6] further focused studies of
the interactions between TS and its ligands. Combi-
nation of the latter two approaches has identified no
fewer than 13 residues that interact directly, via hydrogen
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bonding or hydrophobic interactions, or indirectly, via
water molecules, with the substrate dUMP. The result-
ing network of contacts (Figure 1) illustrates the com-
plexity of the interaction between TS and dUMP.
Many single- and multiple-site mutants of TS have been
studied, both kinetically and structurally (reviewed in
[1]), to address the binding of ligands and the catalytic
mechanism of the enzyme. The atomic-resolution struc-
tures of TS and its mutants implicate these residues
in substrate-binding affinity, orientation and specificity.
Enzymes show considerable plasticity of mutant com-
pensation and ligand binding, however [7]. In addi-
tion, very few residues are completely essential to the
TS reaction (reviewed in [1]). Most problems associated
with the use of site-directed mutagenesis to analyse an
enzyme reaction are due to the inability to use genetic
means to make small chemical changes at a particular
position in the protein as, with few exceptions, the 20
naturally occurring amino acids are very different from
each other. As a consequence, most amino acid sequence
changes result in relatively large changes in molecular
volume and local electrostatics, adding to the complexity
of interpreting the chemical and structural rearrange-
ments of the protein; the determination of the conse-
quences of these changes on the enzyme reaction mecha-
nism is also complicated.
In this study, we analyse the TS reaction — both biochem-
ically and structurally — by systematically removing func-
tional moieties of the substrate, dUMP. This was planned
as an inversion of the usual process of dissecting enzymatic
reactions by looking, not at modulations in the protein and
their effects on the ligands through site-directed mutagen-
esis, but rather at incremental modifications in the bound
ligands and their effect on the mode of binding. Com-
plexes were studied with and without the cofactor
analogue CB3717, and a range of dUMP ‘fragments’
(Figure 2). These fragments included intact 2′-deoxy-
uridine monophosphate (dUMP) (1), 2′-deoxyuridine
(dUrd) (2), 2′,5′-dideoxyuridine (ddUrd) (3), uridine (Urd)
(4), phosphoribose (PR) (5), and phosphate (PO42–) (6). In
each case, the composition of the protein scaffold remained
constant and any changes in interactions can be interpreted
as important aspects of the binding of the fragments. This
approach allows the analysis of changes in enzyme–sub-
strate interactions without altering the enzyme itself. The
results complement and extend site-directed mutagenesis
studies to help pinpoint the shared roles of substrates, sub-
strate analogues and the protein in enzymatic reactions.
Results and discussion
The substrate and fragments studied are described in the
Materials and methods section and are summarised in
Figure 2. 
840 Structure 1998, Vol 6 No 7
Figure 1
O
 Trp82
N
His199
N
HN
Asn 229 N
 Ser232
OH
P 
O
O
O
O
O
NO
N
O
HO
H
O
H
H
OWat180
H
H
O
H
H
H
H
S Cys 198
H
H
O
H
Tyr261
O
Tyr146HO
Arg218
H
NH2N
NH2
Arg 179'
NH
H2N
H2N
Arg23
HN NH2
NH2
Arg178'
NH2N
NH2
H O
N
Asp221
H
Gln217
His259
HN
N
H
H
H
O
 Glu60
O N
H
H
O
O
 Trp82
N
His199
N
HN
Asn 229 N
 Ser232
OH
P 
O
O
O
O
O
NO
N
O
HO
H
O
H
H
OWat180
H
H
O
H
H
H
H
S Cys198
H
H
O
H
Tyr261
O
Tyr146HO
Arg218
H
NH2N
NH2
Arg179'
NH
H2N
H2N
Arg23
HN NH2
NH2
Arg 178'
NH2N
NH2
H O
N
Asp 221
H
Gln 217
His259
HN
N
H
H
H
O
 Glu 60
O N
H
H
O
O
 Trp82
N
His199
N
HN
Asn 229 N
 Ser 232
OH
P 
O
O
O
O
O
HO
H
O
H
H
OWat180
H
H
O
H
H
H
H
S Cys198
H
O
H
Tyr261
O
Tyr146HO
Arg218
H
NH2N
NH2
Arg 179'
NH
H2N
H2N
Arg 23
HN NH2
NH2
Arg178'
NH2N
NH2
H O
N
Asp221
H
Gln217
His259
HN
N
H
H
H
O
 Glu 60
O N
H
H
O
Wat229
Wat1
WatC7
Wat229a
Wat229
Wat1
WatC7
Wat229a
Wat229
Wat1
WatC7
Wat229a
(a) (b) (c)
Structure
An extensive hydrogen-bond network of interactions is formed
between TS and the substrate dUMP. Substrate fragments utilise
subsets of this same network. (a) In the presence of a cofactor
analogue (not shown), dUMP forms a covalent adduct with the
catalytic cysteine residue of TS. (b) The complex of the substrate
fragments ddUrd and PO42– with TS in the presence of a cofactor
analogue (not shown) does not perturb any of these interactions but
does not form the covalent adduct with the enzyme. Relative to the
natural substrate, dUMP, this is equivalent to removal of the glycosidic
bond. (c) The complexes of the substrate fragment phosphoribose
(PR) with TS both with and without the cofactor analogue display
rotational disorder about the glycosidic linkage. Thus, the specific
interactions between the ribose moiety and the enzyme are either
greatly reduced or eliminated, relative to the natural substrate complex,
by the ‘loss’ of the pyrimidine ring.
Substrate influence on protein structure
By comparing the structure of the apoenzyme with that of
TS in complex with the natural substrate, dUMP, we can
elucidate the influence of the ligand on the protein struc-
ture. As the apoenzyme crystals are grown from 20 mM
KPO4 buffer, the phosphate-binding site is fully occupied
in the apoTS crystal structure. Thus, the comparison is, in
effect, between the complexes of TS with the bound sub-
strate fragments PO42– (6) and dUMP (1). Globally, there
are minimal effects on the structure of TS following the
binding of dUMP. The root mean square (rms) devia-
tion for Cα atoms between the two complexes is 0.18 Å
(Table 1), well within the experimental error. Within the
active site, however, there are a number of rearrangements
by the specificity framework of the protein to accommo-
date the substrate molecule. Two well ordered water mol-
ecules are displaced by the dUMP; water 403 occupied a
site in the PO42– bound structure very near C6 of dUMP,
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The substrate fragments. The natural substrate of TS, dUMP (1), can
be subdivided into several fragments, of which various combinations
are commercially available. These include 2′-deoxyuridine (dUrd; 2),
2′,5′-dideoxyuridine (ddUrd; 3), uridine (Urd; 4), phosphoribose (PR;
5), and phosphate (PO42–; 6).
Table 1
Structural comparisons.
apo + dUMP + dUrd + dUMP + CB + dUrd + CB + ddUrd + CB + CB
3TMS
Cα 0.19 (7.9)
main 0.19 (7.9)
all 0.53 (9.9)
2TSC
Cα 0.22 (5.4)
main 0.22 (5.4)
all 0.78 (6.7)
apoTS
Cα  0.18 (4.9) 0.18 (3.3)
main – 0.17 (4.9) 0.18 (3.3)
all 0.78 (6.3) 0.63 (4.9)
TS + dUMP + CB3717
Cα 0.24 (5.6) 0.25 (5.7) 0.23 (7.0)
main – 0.27 (5.8) 0.25 (5.7) 0.21 (7.4)
all 0.73 (6.5) 0.67 (6.6) 0.56 (8.1)
The values given are root mean square deviations (rmsds) on atomic
coordinates (x,y,z); values in parentheses are rmsds on the differences
in B factors (rms ∆B). All values are in Å2 and all superpositions were
performed using the program lsqman [35]. CB, CB3717; Cα, α
carbons only; main, backbone atoms (C, N, Cα); all, all protein atoms.
3TMS and 2TSC are the PDB entry codes for prior determinations of
the apoTS and TS + dUMP + CB3717 complexes, respectively.
and water 365 is displaced from a point occupied by C4 of
the substrate. The sidechain of Asn177 rotates by 180°
about the Cα–Cβ bond and Cγ is translated by 1.2 Å to
form dual hydrogen bonds with N3 and O4 of dUMP. The
sidechain of Gln165 also flips, and Cδ is translated by
0.8 Å to preserve the hydrogen-bonding network. Trp83
and Val143 are also seen to reorient into rotomers 180°
opposed to those found in the PO42– only structure. There
is very little movement in the residues that form hydrogen
bonds with the ribose moiety; Tyr209, His207 and Asp169
all move 0.35 Å. This region of the active site appears to
be preorganized for substrate binding.
Cofactor influence on protein structure
The apoenzyme structure can also be compared to the
crystal structure of TS in complex with the cofactor ana-
logue CB3717 alone as a means of discerning the influ-
ence of the cofactor analogue on the conformation of the
protein. The structure of TS in complex with CB3717
supports previous observations [4,7–9] that it is the cofac-
tor that triggers ‘closure’ of the active site, principally
through the movement of the C terminus towards the
reactive center. The cofactor facilitates this through a
number of contacts, both specific and hydrophobic. The
quinazoline moiety participates in a hydrogen-bond
network bridging the C terminus to the arginine pocket
that binds the phosphate of the substrate. In addition, the
aromatic des-amino ring of the quinazoline and the
benzene ring of the para-amino benzoic acid (PABA) moi-
eties form favourable hydrophobic-packing interactions
with a large portion of the active site, drawing distal walls
together and excluding nonspecific waters. In contrast to
an earlier study [4], our analysis of the crystal structure of
TS complexed with CB3717 in the absence of substrate
shows a distinctly different binding mode for the cofactor
analogue (Figure 3). Our analysis of this complex shows
that what appeared to be disordered binding in the previ-
ously published structure of this complex is — at least in
this redetermination — a well ordered binding mode
which is fully occupied in both monomers of the crystallo-
graphically unique dimer. The cofactor adopts an orienta-
tion very similar to that we recently described in the
second monomer of the Glu58→Gln mutant crystal struc-
ture [10]. The quinazoline is rotated about the C9–N10
bond angle by ~90°, bringing N2 to a separation of 3.0 Å
from the reactive thiol at Cys146. In addition, the N1–C4
portions of the quinazoline pass essentially through the
space occupied by C6–C5 of the pyrimidine ring in the
ternary complex with CB3717 and dUMP. The volume
occupied by the quinazoline moiety in its ‘catalytically
competent’ orientation is, in this structure, filled with
three well ordered water molecules: Wat767, Wat781 and
Wat789. In addition to the close interaction with the
active-site cysteine, CB3717 makes four additional hydro-
gen bonds which are unique to this conformation. These
interactions are with Ala144 (N2′→O; 2.6 Å), Tyr94
(OA4′→Oη; 2.8 Å), His147 (OA4′→Nε2; 3.2 Å), and the
conserved water that anchors O4 of dUMP (OA4′→Wat771;
2.9 Å). This conformation of the cofactor analogue may rep-
resent a ‘pre-ordered’ or ‘pre-catalytically competent’ ori-
entation of the cofactor. In addition, the very close
interaction between the free amine at the tip of the quina-
zoline and the active-site cysteine immediately presents
itself as an intriguing new avenue of inquiry for rational
drug design against TS. Modification of N2 from a
primary amine to a functional group that can covalently
interact with the reactive-site cysteine would bring the
mechanism-based advantages of substrate analogues, for
example 5-fluorouracil (5FU) [11,12], together with the
cell accessibility advantages of a cofactor analogue, for
example CB3717 [13–18], BW1843U89 [13,19,20] and
Tomudex [21–23].
Effect of the cofactor on dUMP binding
A number of differences are induced in the protein
structure on cofactor binding; most of these have been
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Figure 3
Stereoview superposition of the binary
complex of E. coli TS with CB3717 (1AN5;
green) and the ternary complex of TS with
CB3717 and dUMP (1KCE; dark grey). In the
binary complex of CB3717 with TS, the
cofactor analogue adopts the ‘precompetent’
binding mode which is accessible in the
absence of substrate. In this figure, and
figures 4–6, the ‘reference’ ligands — dUMP
and CB3717 — are depicted in dark grey,
while each of the structures of fragment
complexes are depicted in a unique colour.
The catalytic cysteine of the enzyme is
depicted in the colour corresponding to the
appropriate complex.
discussed previously [4,7,8]. Principally, they include a
‘closure’ of the active site through a concerted inward
movement of the C terminus toward the cofactor. A com-
parison of the binary TS–dUMP complex with the ternary
complex formed between TS, dUMP and CB3717 demon-
strates the effect that the cofactor exerts on the binding
mode of the substrate. By aligning the proteins through a
least-squares fit of the Cα atoms which deviate by less
than 1 Å from the aligned positions (thereby selecting a
best-fitting subset of the protein and neglecting regions of
large conformational change; in this case the C-terminal
four residues) [24], a direct comparison of the active sites
with substrate and both with and without the presence of
cofactor was made. The most immediately obvious differ-
ence is that in the ternary complex, dUMP forms a cova-
lent adduct with Sγ of Cys146. This is a well known initial
step in the reaction mechanism [1], and is trapped by the
cofactor analogue CB3717 [25]. In addition, it is clear that
the presence of the cofactor analogue induces some
increase in conformational energy in the substrate by
pressing the ribose and pyrimidine moieties closer towards
the reactive thiol while the phosphate remains rigidly in
place, anchored by the four arginines of the phosphate-
binding pocket. On average, the pyrimidine is moved
~0.9 Å towards Cys146, while the ribose moves ~0.7 Å. In
particular, C6 of the pyrimidine is moved 1.2 Å, and it has
been postulated (reviewed in [26]) that this enhanced
proximity of the pyrimidine to the reactive thiol initiates
the TS reaction. Binding studies have also shown [27] that
the addition of CB3717 enhances the affinity of the sub-
strate by around threefold relative to binary complexes.
This increase in affinity is reflected in the degree of order
in the crystal structures of dUMP in complex with TS
both with and without bound antifolate inhibitor CB3717:
after normalization based on the average B factor of the
protein, the average difference in thermal parameters for
the substrate (<∆B>) is 21.3 Å2 (relative to an average ∆B
of zero for the normalised protein B factors) suggesting
that the increase in affinity is a result of a decrease in the
local entropy of the ligand. Thus, the addition of CB3717
has principally contributed to an ordering of dUMP
binding, as well as to a localisation of the substrate in close
proximity to the reactive thiol.
‘Loss’ of the glycosidic bond
2′-Deoxyuridine (dUrd) differs chemically from the
natural substrate, dUMP, by the absence of the phos-
phate moiety (see Figure 1). The ‘loss’ of this phosphate
group reduces the binding of dUrd (Km = 0.2 mM [28,29])
to TS by 500-fold relative to dUMP. We have measured
the propensity of dUrd to inhibit the Escherichia coli TS
reaction and found no measurable diminution of enzyme
activity, even in the presence of 20 mM dUrd. When the
natural substrate, dUMP, is substituted in the binary crys-
talline complex by 2′-deoxyuridine (dUrd) and a phos-
phate ion, PO42– (6), there are minimal differences found
in the mode of binding (Figure 4; Table 1). There is a
small shift (~0.2 Å) in the center of mass of the dUrd mol-
ecule away from the phosphate-binding site and toward
Asn177 which coordinates the pyrimidine ring. There is a
corresponding movement of the Asn177 sidechain to
track this movement, thereby maintaining the double
hydrogen bonds between Asn177 and N3 and O4 of the
pyrimidine.
It is in the ternary complexes of dUMP and dUrd with TS
and CB3717, that the most distinct differences are found
between the binding aspects of the substrate fragments
(Figure 5). In the binary complexes, dUMP and dUrd
bind in a very similar manner, but the presence of the
cofactor analogue demonstrates the very different interac-
tions with the enzyme that these substrate fragments
make. Most prominently, whereas the presence of
CB3717 promotes the covalent addition of dUMP to Sγ of
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Figure 4
Stereoview superposition of the binary
complexes of E. coli TS with dUrd (1BDU;
yellow) and TS with dUMP (1BID; dark grey).
The absence of the covalent tether between
dUrd and the PO42– allows movement of the
ribose moiety and the phosphate ion away
from one another relative to their positions in
the dUMP complex.
Cys146, this Michael adduct is not formed in the ternary
complex of CB3717 with dUrd. The effect of CB3717 on
the binding mode of dUrd is similar to the difference
found between the binary dUMP complex and the ternary
TS–CB3717–dUMP complex, where the presence of the
cofactor analogue has pressed the pyrimidine ring of
dUMP closer to Cys146. In the TS–CB3717–dUrd ternary
complex, the pyrimidine ring is moved ~0.9 Å in the direc-
tion of Cys146 relative to the binary dUrd complex;
however, there is no covalent attachment made between
C6 of dUrd and the Sγ of Cys146. The presence of a cova-
lent attachment is very clear in the TS–dUMP–CB3717
ternary complex: C6 of dUMP and Sγ of Cys146 are sepa-
rated by ~1.8 Å, and the pyrimidine ring of dUMP can
clearly be seen to be nonplanar. Each of these features
was determined from difference electron-density maps
from which dUMP/dUrd and Cys146 have been omitted.
In the ternary TS–dUrd–CB3717 complex, difference
electron density unambiguously demonstrated the pla-
narity of the pyrimidine, as well as the much larger separa-
tion between C6 and Sγ which, after refinement, was
found to be 3.8 Å. In addition, the cysteine could be seen
to have moved ~1 Å away from the pyrimidine-binding
site. Without the constraints of the phosphate fragment,
dUrd is found to undergo a concerted rotation away from
both the phosphate-binding site and the reactive thiol.
The side of dUrd that anchors the molecule to the protein,
encompassing C2–N3 and CR2–CR3, moves less than
0.1 Å from the same atomic positions found in the ternary
complex with dUMP. The opposite side of the molecule,
however, encompassing C5–C6 and OR1–CR1, rotates
away from Cys146 and the phosphate-binding site by an
average of 0.5 Å. The inability of dUrd to covalently
attach to TS in the presence of the cofactor analogue, indi-
cates that the phosphate moiety and its interaction with
the remainder of the substrate have a fundamental role in
the initial stages of the TS reaction.
Effect of the 5¢-terminal hydroxyl
To investigate the role of the 5′-hydroxyl group included
on dUrd (and essentially duplicated in the phosphate ion),
we also cocrystallised and determined the structures of
binary and ternary complexes of TS with 2′,5′-dideoxy-
uridine (ddUrd). In both cases, the binding mode of the
ddUrd moiety (Figure 6) is nearly identical to that
observed for dUrd. ddUrd displays the same ‘released’
and relaxed behaviour relative to the binding mode of
dUMP as described above for dUrd. Both binary and
ternary complexes of ddUrd with TS do, however, show
larger B factors for the ddUrd after normalisation of the
protein B factors against the dUrd complexes. This would
seem to indicate that, although the 5′-hydroxyl does not
form any apparent hydrogen bonds with the protein or
with the crystallographically ordered solvent, it does seem
to play some part in reducing the local entropy of the
binding mode.
If the difference between dUMP and dUrd/ddUrd can be
thought of as the ‘loss’ of the glycosidic bond, then the
complexes can be compared as ‘before’ and ‘after’ end-
points encompassing the breakage of this bond. The com-
plexes of TS with dUrd or ddUrd and phosphate show
that the release of the anchoring aspects of the phosphate
moiety allows global movement of dUrd/ddUrd away
from the phosphate-binding site as well as a rotation of
the 5′-terminal hydroxyl group away from the phosphate
ion (in the case of dUrd). As dUrd/ddUrd is no longer
anchored into the phosphate-binding site, there is a rota-
tional shift of the ribose ring away from the phosphate-
binding site, presumably relieving the substantial amount
of strain that is induced into dUMP by its multiple site
attachments. We propose that it is, in part, this stereo-
chemical strain induced into dUMP by the anchoring of
the phosphate and the pyrimidine to the enzyme, and
enhanced by the presence of the cofactor, which activates
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Figure 5
Stereoview superposition of the ternary
complexes of E. coli TS with CB3717 and
dUrd (1TDU; yellow) and with CB3717 and
dUMP (1KCE; dark grey). These complexes
differ from those depicted in Figure 4 by the
additional presence of the cofactor analogue
CB3717. Here we see that whereas CB3717
facilitates the covalent attachment of dUMP to
Cys146, there is no crystallographically
detectable attachment between dUrd and the
enzyme.
C6 of the pyrimidine ring, making this carbon susceptible
to attack by the active-site thiol.
‘Loss’ of the ribose
Binary and ternary complexes were also obtained
containing both of the substrate fragments uridine (Urd)
and phosphate (PO42–). These fragments correspond to
all of the components of dUMP binding with the ribose
sugar ring removed. In a serial progression from
dUMP→dUrd→ddUrd→Urd, the removal of the ribose
demonstrates a dramatic effect on the coherence of
binding to TS. In both the binary and ternary complexes
with Urd, the pyrimidine was found to be very poorly
ordered in the active site. The principal orienting inter-
actions with Asn177 are maintained; however, the ligand
is librationally disordered. Relative to the complexes
with dUrd and ddUrd, it can be inferred that the princi-
pal contribution of the ribose moiety to ligand binding is
to enhance the binding affinity and reduce the local
entropy of the substrate within the active site. This is
probably accomplished both through the conformational
inflexibility of the five-membered ring and the stereo-
specificity of the hydrogen bonds formed between O3′
and Tyr209 and His207.
Nonspecific binding of phosphoribose
Attempts were also made to form binary and ternary com-
plexes with phosphoribose (PR). Cocrystallisations were
set up in the same manner as for each of the other com-
plexes, and data were collected. Difference electron-
density maps, however, did not show readily interpretable
electron density for this substrate fragment. The ∆Fo
(FPR–Fapo and FCB,PR–FCB) electron-density maps show a
very strong peak for the phosphate ion which is elongated
in the direction of the ribose moiety; however, there is no
clearly interpretable orientation in which the ribose can
be modelled. Similar maps calculated for crystals contain-
ing only PO42– show very spherical/tetrahedral density at
the phosphate-binding site. The comma-shaped elonga-
tion of the difference density makes it clear that PR is
present at full occupancy; however, the ribose is rotation-
ally disordered about the glycosidic linkage. This result is
just as informationally rich as the clearly modelled com-
plexes in telling us what is important about the binding of
substrate to the enzyme. The inability of phosphate-teth-
ered ribose to interact in an ordered manner with the
active site without the presence of the pyrimidine ring
indicates that the pyrimidine is the principal determinant
of binding modality for substrate within the active site. In
addition, this observation suggests that the role of the
ribose is to confer additional specificity, to enhance the
strength of the substrate–protein interaction (through
multiple hydrogen bonds), and perhaps to serve as a steric
bridge between the phosphate-binding site and C6 of the
pyrimidine.
Conclusions
This study has shown that analysis of the binding of
ligands to enzymes by considering the binding modes and
affinities of fragments of the native substrate can reveal
insights into the requirements for ligand binding. It can be
postulated from these observations that the binding of
ligand fragments may conform to the principles of additiv-
ity, enabling new in-roads into the design of enzyme
inhibitors and therapeutics. This study of protein–ligand
interactions via the interactions of the enzyme with ligand
fragments is complementary to approaches utilising site-
directed mutagenesis of the enzyme. In the case of TS, we
have found that the binding orientation of dUMP is prin-
cipally directed by the pyrimidine ring. We have also
found that the ribose sugar moiety contributes a certain
degree of specificity, as other sugars are not tolerated, and
also greatly enhances the spatial localisation of substrate
within the active site. In addition, we have found that the
glycosidic linkage is critical to the precise localisation and
activation of the substrate for initiation of the enzymatic
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Figure 6
Stereoview superposition of the ternary
complexes of E. coli TS with CB3717 and
ddUrd (1DDU; red) and with CB3717 and
dUMP (1KCE; dark grey). 
reaction. This reduction in local entropy may be crucial to
the turnover rate of enzymatic activity.
Biological implications
Throughout nature, enzymes have responded to evolu-
tionary pressures by evolving the ability to recognise
their target substrates with extraordinary selectivity and
specificity. For example, Lactobacillus casei thymidylate
synthase (TS) preferentially binds dUMP over dCMP by
approximately 500-fold [30] via a mechanism that has
recently been exploited to produce a re-engineered TS
with a tenfold reversal in ligand-recognition affinity [31].
The complex interactions which have evolved between
ligand and enzyme complicate the process of both under-
standing the exceptional chemistry performed by
enzymes, as well as our ability to readily exploit the
active-site features that must be targeted in the design of
enzymatic inhibitors. Optimisation of this process is of
fundamental importance to streamlining the design of
medicinal therapeutics if we are to move lead compounds
to clinical candidates in a timely manner.
Structural as well as kinetic studies of the interactions
between enzymes and their substrates have generally
found that multiple interactions are often generated
around the available ‘hooks’ presented by the sub-
strate. Whether fragments of the substrate —probably
never available to the evolving enzyme —are bound in
the same manner as the parent substrate addresses the
fundamental basis of specificity. An understanding of
the relative contributions of individual portions of
ligand molecules to the enzyme-binding interaction may
offer considerable insight into the principles of sub-
strate recognition.
In all cells, TS provides the last step in the only
synthetic pathway for the production of thymidine.
Because rapidly dividing cells, such as those in the
cancerous state, have a particularly high demand for
DNA production and thus for thymidine, TS has
become an attractive target for anticancer drug design.
Much work has focused on TS as a drug design target;
however, to date, only the pro-drug 5-fluorouracil
(5FU) [11,12] is widely approved as a TS-inhibiting
anticancer therapy. 5FU is a mechanism-based inhib-
itor, meaning that it takes advantage of the natural
ligand-binding affinities and chemistry of TS to
‘trap’ the enzyme in a complex that can no longer
produce products. In this study, we have sought to
break apart the natural binding affinity of the substrate,
dUMP, into its various modular components. An
understanding of which components of the substrate
are crucial to binding and to the chemical mechanism
will lead to better rational design of anticancer drugs
directed against this enzyme. Towards this end, we
have examined the crystal structures of TS in complex
with rational chemical subsets of dUMP. On the basis
of these structures, we can deduce the relative impor-
tance of each fragment to the interactions made
between the natural substrate and the protein. This
approach complements the understanding of ligand–
protein interactions obtained by site-directed mutagene-
sis, wherein the protein is modulated through amino
acid changes and the resulting effects on the binding of
substrate are studied.
Materials and methods
Substrate fragments
All the substrate fragments were purchased from Sigma. They include
the intact substrate 2′,5′-deoxyuridine monophosphate (dUMP, 1 in
Figure 1), a fragment incorporating all of dUMP minus the phosphate,
2′-deoxyuridine (dUrd, 2); a fragment which is also missing the ribose/
phosphate ‘linkage’ oxygen, 2′,5′-dideoxyuridine (ddUrd, 3); a fragment
consisting only of the pyrimidine ring, uracil (Urd, 4); a fragment lacking
the pyrimidine, phosphoribose (PR, 5); and a fragment consisting only
of the phosphate moiety (PO42–, 6).
Cocrystallisation
E. coli TS was expressed and purified as described previously [10].
Crystals of each of the complexes were formed by cocrystallisation of
TS with the ligands. ‘Binary’ crystallisation experiments (those not con-
taining the cofactor analogue, CB3717) were conducted in hanging
drops containing ~4.2 mg/ml E. coli TS, 0.38 mM dUMP, dUrd, ddUrd,
Urd or PR, 3.8 mM DTT, and 1.2 M (NH4)2SO4, at pH 7.8 (20 mM KPO4)
suspended over a well solution containing 2.4 M (NH4)2SO4 and
1.0 mM DTT. ‘Ternary’ crystallisation experiments (those including
CB3717) were conducted in hanging drops containing ~4.2 mg/ml E.
coli TS, 0.38 mM dUMP, dUrd, ddUrd, Urd or PR, 3.8 mM DTT, 1.0 mM
CB3717 and 1.2 M (NH4)2SO4, pH 7.8 (20 mM KPO4) over a well
solution containing 2.4 M (NH4)2SO4 and 1.0 mM DTT. The final
volume of the droplets was 5 µl. Cubes and icosahedra (binary com-
plexes) or hexagonal rods (ternary complexes) grew within 3 days. The
largest binary complex crystals typically grew to 350–400 µm3, while
ternary crystals were typically 250 × 250 × 600 µm. Binary crystals
belong to the cubic space group I213, with a = 133.2 Å, and ternary
crystals belong to space group P63, with a = 127.35 Å and
c = 68.16 Å. The cubic form contains one E. coli TS monomer per
asymmetric unit, whereas the hexagonal form contains a full dimer in
the asymmetric unit. In a small percentage of crystallisations, ternary
complex crystals are found in the trigonal spacegroup, P3121
(a = 71.96 Å, c = 115.1 Å).
X-ray data collection
All X-ray diffraction data were collected on an R-Axis IIc imaging plate
with a Rigaku RU-200 rotating anode generator operating at 15 kW
(50 mA and 300 kV) fitted with a Cu anode (λ = 1.5418 Å). The
crystal-to-detector distance was 100 mm for the body-centered cubic
crystals (apo and ‘binary’ complexes), and 120 mm for the primitive
lattice hexagonal crystals (‘ternary’ complexes). Exposures of 20 min
per 1° oscillation range were used throughout all of the data collec-
tions. The diffraction data were indexed, integrated, scaled and merged
with the HKL software package [32]. A summary of the data-process-
ing statistics is presented in Table 2.
Structure solution and refinement: binary complexes
For each of the binary complexes, a model consisting of one monomer
of E. coli TS in the binary complex form [7], excluding all waters and
ligands was used to calculate an initial difference electron density syn-
thesis (Fo–Fc) using all data between 15-2.5 Å. dUMP or dUMP frag-
ments were built into the resulting difference density and refined using
X-PLOR [33]. Waters were added to the structures by an automated
peak picking procedure which selected 3σ or greater peaks from Fo–Fc
difference density maps which also satisfied proper criteria for water
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molecule positions — including at least one proper hydrogen-bonding
partner (either protein, ligand or bridging waters) and good stereochem-
istry. Once all of the significant difference density was accounted for,
refinement was extended to the ultimate resolution limit of the structure
being considered. All of the structures were examined for adherence to
good stereochemical parameters without over-refinement (Table 3).
Structure solution and refinement: ternary complexes
For each of the ternary complexes, a model of a complete dimer of E.
coli TS in the ternary complex form [8], excluding all waters and ligands
was used to calculate an initial difference electron density synthesis
(Fo–Fc) using all data between 15–2.5 Å. CB3717 was built into the
resulting difference density first, using the density visualisation
program, CHAIN [34], and refined against the diffraction data using the
program X-PLOR [33]; subsequent difference density maps were used
to place the dUMP or dUMP fragments which were built into this differ-
ence density and refined. Waters were added to the structures by an
automated peak picking procedure which selected 3σ or greater peaks
from Fo–Fc difference density maps which also satisfied proper criteria
for water molecule positions — including at least one proper hydrogen-
bonding partner (either protein, ligand or bridging waters) and good
stereochemistry. Once all of the significant difference density was
accounted for, refinement was extended to the ultimate resolution limit
of the structure being considered, and each of the structures was
examined for adherence to good stereochemical parameters without
over-refinement (Table 3).
Accession numbers
The coordinates of the structure of TS and the various complexes
reported here have been deposited with the Brookhaven Protein Data
Bank. Entry codes: apoTS, 1TJS; binary TS + dUMP, 1BID; binary TS
+ dUrd + PO42–, 1BDU; binary TS + ddUrd + PO42–, 1AOB; ternary
TS + CB3717 + dUMP, 1KCE; ternary TS + CB3717 + dUrd +
PO42–, 1TDU; ternary TS + CB3717 + ddUrd + PO42–, 1DDU; ternary
TS + CB3717 + PO42–, 1AN5; crystallographically symmetric ternary
TS + CB3717 + dUMP, 1TRG. 
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Table 2
Crystallographic data statistics*.
+ dUMP + dUrd + ddUrd + Urd
apo + dUMP + dUrd + ddUrd + Urd + CB + CB + CB + CB + CB
Resolution (Å) 2.20 2.10 2.10 2.10 2.20 2.00 2.10 2.10 2.50 2.6
Observed reflections† 61,026 92,187 68,944 76,509 32,842 109,083 148,364 55,680 29,322 76,707
Unique reflections 18,520 22,297 21,786 20,597 17,015 37,807 35,043 25,970 15,999 19,013
Completeness (%) 92.7 96.9 95.0 89.7 85.1 90.0 95.2 70.1 72.8 97.4
(85.7) (91.5) (89.2) (74.5) (71.7) (69.3) (90.2) (49.8) (52.8) (94.3)
Rsym (%) 0.070 0.074 0.096 0.098 0.076 0.097 0.064 0.133 0.132 0.109
(0.273) (0.319) (0.366) (0.340) (0.207) (0.261) (0.278) (0.252) (0.262) (0.300)
Rmerge (%) 21.3‡ 23.4§〈Redundancy〉 3.5 4.2 3.2 3.7 1.9 2.9 4.2 2.1 1.8 4.0
Refinement resolution (Å) 7–2.2 7–2.1 7–2.1 7–2.1 7–2.5 7–1.95 7–2.1 7–2.1 7–2.5 7–2.6
Refined R factor 0.190 0.179 0.181 0.193 0.160 0.172 0.185 0.162 0.162
R free 0.243 0.217 0.237 0.243 0.221 0.221 0.246 0.256 0.244
No. of modelled waters 99 113 68 0 106 241 153 66 172
Average B (protein) (Å2) 23.3 26.9 21.1 22.0 20.8 20.9 24.8 22.8 17.44
Average B (substrate) (Å2) – 53.2 77.1 72.7 ind# 16.9 35.6 84.9 –
Average B (CB3717) (Å2) – – – – – 27.3 47.1 75.7 39.87
Average B (water) (Å2) 39.5 40.6 39.0 – 36.6 35.7 33.1 37.0 34.04
*Numbers in parentheses refer to the highest resolution shell; CB, CB3717. †(I/σ(I) > 1.0). ‡versus 3TMS and §versus 2TSC, where 3TMS and
2TSC are the PDB entry codes for previous determinations of the apoTS and ternary TS + dUMP + CB3717 structures, respectively. #ind,
indeterminate. 
Table 3
Stereochemical summaries.
Accession No. Ramachandran (%)* Bond lengths (%)† Bond angles (%)† Planar groups (%)† G factors‡
3TMS 91.3, 8.7, 0.0, 0.0 87.7, 12.3 62.7, 37.3 88.9, 11.1 –0.29, –0.66, –0.39
2TSC 89.8,10.0, 0.0, 0.2 73.0, 27.0 43.8, 56.2 94.3, 5.7 –0.10, –2.20, –0.82
1TJS 89.6, 10.4, 0.0, 0.0 100.0, 0.0 83.7, 16.3 86.3, 13.7 0.05, 0.41, 0.20
1KCE 92.8, 7.2, 0.0, 0.0 100.0, 0.0 86.6, 13.4 88.6, 11.4 0.21, 0.47, 0.32
1BDU 92.2, 7.8, 0.0, 0.0 98.0, 2.0 73.7, 26.3 89.3, 10.7 –0.14, –0.19, –0.13
1TDU 89.8, 9.8, 0.4, 0.0 97.3, 2.7 71.5, 28.5 88.6, 11.4 –0.19, –0.13, –0.13
1AOB 91.7, 8.3, 0.0, 0.0 95.3, 4.7 74.8, 25.2 96.4, 3.6 –0.10, –0.13, –0.08
1DDU 87.8, 12.0, 0.2, 0.0 91.7, 8.3 67.7, 32.3 92.9, 7.1 –0.23, –0.16, –0.20
1AN5 89.1, 10.9, 0.0, 0.0 100.0, 0.0 86.5, 13.5 82.6, 17.4 0.15, 0.48, 0.29
*The percentage of residues falling within core, allowed, generously
allowed, and disallowed zones [36]. †The percentage of residues
falling within generally observed limits, and the percentage flagged as
unusual . ‡G factors for dihedral angles, covalent bonds and the overall
combined value [37].
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